ESMO 2025丨An Academic Feast Awaits — Highlights from the Uro-Oncology Field You Won’t Want to Miss!

ESMO 2025丨An Academic Feast Awaits — Highlights from the Uro-Oncology Field You Won’t Want to Miss!

2025.10.16
At the highly anticipated ESMO Congress, a wealth of cutting-edge advances will be presented, with uro-oncology standing out as one of the most vibrant and fast-evolving fields. This year, 22 Late-Breaking Abstracts (LBAs) will be showcased, accounting for nearly half of all oral presentations (45 in total) within the uro-oncology track — a testament to the field’s dynamic research momentum and strong clinical relevance.Oncology Frontier – Urology Frontier has carefully selected ten key studies and invited leading Chinese experts to share their insights and expectations.
ISEH 2025 | Professor Fumio Arai: Regulatory Mechanisms of Hematopoietic Stem Cell Quiescence and Their Clinical Translation Prospects

ISEH 2025 | Professor Fumio Arai: Regulatory Mechanisms of Hematopoietic Stem Cell Quiescence and Their Clinical Translation Prospects

2025.10.14
The 54th Annual Scientific Meeting of the International Society for Experimental Hematology (ISEH 2025) was held from September 24–27, 2025, in Kumamoto, Japan, bringing together leading global experts in hematology to discuss cutting-edge advances in basic hematology, immunology, stem cell research, and cell and gene therapy. One of the major highlights of the event was the Sino-Japanese Joint Symposium on Stem Cells and Cellular Therapy, which drew wide attention. At the symposium, Professor Fumio Arai from Kyushu University, Japan, delivered an insightful presentation titled “Signaling networks governing hematopoietic stem cell quiescence.” In this interview, Oncology Frontier – Hematology Frontier invited Professor Arai to discuss the role of signaling networks in maintaining stem cell function and their potential in clinical applications.
Any level of alcohol can be harmful for MASLD patients

Any level of alcohol can be harmful for MASLD patients

2025.10.12
A recent study by Prof. Wai-Kay Seto (The University of Hong Kong) and Prof. Jie Li (Drum Tower Hospital, Nanjing University Medical School), published in Alimentary Pharmacology & Therapeutics, systematically reviewed the epidemiology, pathogenic mechanisms, and prognostic impact of alcohol use in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), showing that alcohol consumption significantly complicates disease progression and prognosis.
ISEH 2025 | Professor Tao Cheng: Revitalizing Sino-Japanese Hematology Exchange and Exploring the Frontiers of Cell and Gene Therapy

ISEH 2025 | Professor Tao Cheng: Revitalizing Sino-Japanese Hematology Exchange and Exploring the Frontiers of Cell and Gene Therapy

2025.09.30
The 54th Annual Scientific Meeting of the International Society for Experimental Hematology (ISEH 2025) was held from September 24–27 in Kumamoto, Japan. This prestigious event brought together leading experts from around the world to discuss cutting-edge developments in basic hematology, immunology, stem cell research, and cell and gene therapy. One of the highlights of this year’s meeting was the “Sino-Japanese Joint Symposium on Stem Cells and Cellular Therapy,” co-organized by the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (CAMS), and Kumamoto University, marking the successful restart of the Sino-Japanese academic exchange mechanism. During the conference, Oncology Frontier – Hematology Frontier invited Professor Tao Cheng of the Institute of Hematology & Blood Diseases Hospital to share his insights on the origins of this joint symposium, the hottest frontiers in the field, and opportunities for young researchers to engage internationally.
ISEH 2025 China–Japan Dialogue | Prof. Jianxiang Wang and Prof. Naoki Hosen: Direct Insights into CAR-T Therapy for Leukemia and a New Blueprint for International Collaboration 

ISEH 2025 China–Japan Dialogue | Prof. Jianxiang Wang and Prof. Naoki Hosen: Direct Insights into CAR-T Therapy for Leukemia and a New Blueprint for International Collaboration 

2025.09.29
The 54th Annual Scientific Meeting of the International Society for Experimental Hematology (ISEH 2025) was held in Kumamoto, Japan, from September 24–27. The conference brought together leading experts in hematology from around the world to discuss cutting-edge progress in basic hematology, immunology, stem cell research, and cell and gene therapies. During the meeting, Oncology Frontier – Hematology Frontier invited Professor Jianxiang Wang from the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, and Professor Naoki Hosen from Osaka University for a deep dialogue on the latest advances in CAR-T therapy for leukemia. Their discussion covered multiple dimensions — from basic mechanisms and clinical applications to efficacy optimization and future directions — with the shared goal of promoting innovation in CAR-T therapy, advancing international collaboration, and improving global patient access and outcomes.